Comparison of Salivary Interleukin-1β and Matrix Metalloproteinase-8 Levels in Individuals With Chronic Periodontitis

NCT ID: NCT03270280

Last Updated: 2017-09-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE2

Total Enrollment

25 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-09-11

Study Completion Date

2018-04-11

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Periodontitis is an infectious inflammatory disease affecting the periodontal tissue (Gingivae, alveolar bone, periodontal ligament and cementum). Chronic Periodontitis is considered to be the most prevalent disease after dental caries which is linked to increased levels of C- reactive protein, interleukins and matrix metallo-proteinases. Interleukin- 1β and Matrix metalloproteinase-8 have been shown to be robust markers of inflammatory cascade of chronic periodontitis.Various treatment modalities including scaling and root planing, toothpastes and chlorhexidine based mouthwashes have been are known to be associated with various side effects like teeth staining, altered taste sensation, mucosal burning. Hence,the use of natural medicaments could provide a better alternative because of their fewer side effects and cost effectiveness.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Periodontal disease is one of the most common diseases in humans and is responsible for most of the tooth loss in adults. World health Organisation report of 2005 described that the global problem persisted with the worldwide oral diseases such as dental caries, periodontal disease, tooth loss, oral mucosal lesions and oro-pharyngeal cancer. According to a local study the prevalence of periodontitis is found to be more in males of older age group and more in rural areas owing to the lack of awareness of importance of oral hygiene.

Apart from various conventional treatment option for periodontitis a number of herbal medicinal intervention have been used for its treatment. Plant extracts and herbs that have been used previously used for periodontal therapy include Salvadora persica, Arnica Montana and Hamamelis virginiana which have been shown to exhibit antibacterial activity against periodonto-pathic bacteria. Phytomedicines (Medicines derived from herbal plants) like indian gum arabic, aloe vera, nim, carvacrol, garlic, wild coffee and propolis resin have been used in dentistry as anti-inflammatory, antibiotics, analgesic and hypnotic agents. Propolis resin, guava and triphala have been also been used for the treatment of periodontitis

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Periodontitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Healthy Individuals with Chronic Periodontitis Only
Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors
Triple Blind

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Normal Saline

The group contains healthy individuals with chronic periodontitis who will receive Normal Saline as placebo

Group Type PLACEBO_COMPARATOR

Normal saline

Intervention Type DRUG

The individuals will apply 55 drops of Normal saline on gingivae twice daily for two weeks

Nigella Sativa

The group contains healthy individuals with chronic periodontitis who will receive Nigella sativa Oil as intervention

Group Type EXPERIMENTAL

Nigella Sativa Oil

Intervention Type DRUG

The individuals will apply 55 drops of Nigella sativa Oil on gingivae twice daily for two weeks

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Nigella Sativa Oil

The individuals will apply 55 drops of Nigella sativa Oil on gingivae twice daily for two weeks

Intervention Type DRUG

Normal saline

The individuals will apply 55 drops of Normal saline on gingivae twice daily for two weeks

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Black seed Oil Saline

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male and female healthy individual
* Individuals diagnosed with chronic periodontitis according to the WHO criteria.
* Age 19 to 40 years.

Exclusion Criteria

* Patients with gingivitis only.
* Patients using tobacco products and alcohol.
* Underlying systemic pathology such as diabetes mellitus, cardiovascular disease, arthritis etc.
* Oral mucosal pre-neoplastic lesions (leukoplakia, erthroplakia, lichen planus) and oral carcinomas.
* Obese patients.
* Pregnant females.
* Xerostomia.
* Previous history of radiotherapy or chemotherapy.
* Positive history of oral prophylactic procedures (mouthwashes and antibiotics).
* Positive history of any periodontal treatment during last 6 months.
* Positive antibiotic therapy history within last month of study.
Minimum Eligible Age

19 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Health Sciences Lahore

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dr. Ghazala Hassan

Research Scholar

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ghazala Hassan, MPhil

Role: PRINCIPAL_INVESTIGATOR

Research Scholar

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Fatima Memorial Hospital

Lahore, Punjab Province, Pakistan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Pakistan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ghazala Hassan, MPhil

Role: CONTACT

+92 320 4635693

Sarah Ghafoor, PhD

Role: CONTACT

+92 324 4787457

References

Explore related publications, articles, or registry entries linked to this study.

Zadik Y, Bechor R, Galor S, Levin L. Periodontal disease might be associated even with impaired fasting glucose. Br Dent J. 2010 May 22;208(10):E20. doi: 10.1038/sj.bdj.2010.291. Epub 2010 Mar 26.

Reference Type BACKGROUND
PMID: 20339371 (View on PubMed)

Gupta N, Gupta ND, Gupta A, Khan S, Bansal N. Role of salivary matrix metalloproteinase-8 (MMP-8) in chronic periodontitis diagnosis. Front Med. 2015 Mar;9(1):72-6. doi: 10.1007/s11684-014-0347-x. Epub 2014 Aug 6.

Reference Type BACKGROUND
PMID: 25098434 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

UniversityHSL

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.